Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Frederik B. Thunnissen"'
Autor:
Adi F. Gazdar, John D. Minna, John K. Field, George Xinarianos, Triantafillos Liloglou, Jack A. Roth, Eugene Frenkel, Bogdan Czerniak, Ignacio I. Wistuba, Frederik B. Thunnissen, Clemens Prinsen, Yang Xie, Luc Girard, Naoki Okumura, Victor Stastny, Narayan Shivapurkar
Supplementary Figure 2 from Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10300259c4cc667c7509a819f004a2c7
https://doi.org/10.1158/0008-5472.22376525.v1
https://doi.org/10.1158/0008-5472.22376525.v1
Autor:
Adi F. Gazdar, John D. Minna, John K. Field, George Xinarianos, Triantafillos Liloglou, Jack A. Roth, Eugene Frenkel, Bogdan Czerniak, Ignacio I. Wistuba, Frederik B. Thunnissen, Clemens Prinsen, Yang Xie, Luc Girard, Naoki Okumura, Victor Stastny, Narayan Shivapurkar
Supplementary Figure Legends 1-2 from Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7767db4ed9779f4a558c0edbeefdcd89
https://doi.org/10.1158/0008-5472.22376522
https://doi.org/10.1158/0008-5472.22376522
Autor:
Adi F. Gazdar, John D. Minna, John K. Field, George Xinarianos, Triantafillos Liloglou, Jack A. Roth, Eugene Frenkel, Bogdan Czerniak, Ignacio I. Wistuba, Frederik B. Thunnissen, Clemens Prinsen, Yang Xie, Luc Girard, Naoki Okumura, Victor Stastny, Narayan Shivapurkar
Supplementary Figure 1 from Cytoglobin, the Newest Member of the Globin Family, Functions as a Tumor Suppressor Gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::527b4e3a8952d33a9e4bfbe920ff5d15
https://doi.org/10.1158/0008-5472.22376528
https://doi.org/10.1158/0008-5472.22376528
Autor:
Carla Weenink, René M. Vernhout, Kristiaan Nackaerts, Frederik B. Thunnissen, Susan C. van't Westeinde, Rob J. van Klaveren, Matthijs Oudkerk, Willem P.Th.M. Mali, Harry J.M. Groen, Harry J. de Koning, Jan-Willem J. Lammers, Nanda Horeweg
Publikováno v:
Chest, 142(2), 377-384
Chest, 142(2), 377-384. ELSEVIER SCIENCE BV
Chest, 142(2), 377-384. American College of Chest Physicians
Westeinde, S C, Horeweg, N, Vernhout, R M, Groen, H J M, Lammers, J W J, Weenink, C, Nackaerts, K, Oudkerk, M, Mali, W, Thunnissen, F B, Koning, H J & van Klaveren, R J 2012, ' The Role of Conventional Bronchoscopy in the Workup of Suspicious CT Scan Screen-Detected Pulmonary Nodules ', Chest, vol. 142, no. 2, pp. 377-384 . https://doi.org/10.1378/chest.11-2030
Chest, 142(2), 377-384. ELSEVIER SCIENCE BV
Chest, 142(2), 377-384. American College of Chest Physicians
Westeinde, S C, Horeweg, N, Vernhout, R M, Groen, H J M, Lammers, J W J, Weenink, C, Nackaerts, K, Oudkerk, M, Mali, W, Thunnissen, F B, Koning, H J & van Klaveren, R J 2012, ' The Role of Conventional Bronchoscopy in the Workup of Suspicious CT Scan Screen-Detected Pulmonary Nodules ', Chest, vol. 142, no. 2, pp. 377-384 . https://doi.org/10.1378/chest.11-2030
Background: Up to 50% of the participants in CT scan lung cancer screening trials have at least one pulmonary nodule. To date, the role of conventional bronchoscopy in the workup of suspicious screen-detected pulmonary nodules is unknown. If a bronch
Autor:
Harry J. de Koning, Rob J. van Klaveren, Harry J.M. Groen, Carla Weenink, René M. Vernhout, Willem P.Th.M. Mali, Frederik B. Thunnissen, Jan-Willem J. Lammers, Matthijs Oudkerk, Kristiaan Nackaerts, Susan C. van't Westeinde
Publikováno v:
Journal of Thoracic Oncology, 6(10), 1704-1712. International Association for the Study of Lung Cancer
Westeinde, S C, Koning, H J, Thunnissen, F B J M, Oudkerk, M, Groen, H J, Lammers, J W, Weenink, C, Vernhout, R, Nackaerts, K, Mali, W & van Klaveren, RJ 2011, ' The Role of the (18)F-Fluorodeoxyglucose-Positron Emission Tomography Scan in the Nederlands Leuvens Longkanker Screenings Onderzoek Lung Cancer Screening Trial ', Journal of Thoracic Oncology, vol. 6, no. 10, pp. 1704-1712 . https://doi.org/10.1097/JTO.0b013e3182286d0b
Journal of Thoracic Oncology, 6(10), 1704-1712. ELSEVIER SCIENCE INC
Westeinde, S C, Koning, H J, Thunnissen, F B J M, Oudkerk, M, Groen, H J, Lammers, J W, Weenink, C, Vernhout, R, Nackaerts, K, Mali, W & van Klaveren, RJ 2011, ' The Role of the (18)F-Fluorodeoxyglucose-Positron Emission Tomography Scan in the Nederlands Leuvens Longkanker Screenings Onderzoek Lung Cancer Screening Trial ', Journal of Thoracic Oncology, vol. 6, no. 10, pp. 1704-1712 . https://doi.org/10.1097/JTO.0b013e3182286d0b
Journal of Thoracic Oncology, 6(10), 1704-1712. ELSEVIER SCIENCE INC
Background: In computed tomography lung cancer screening programs, up to 30% of all resections are futile.Objective: To investigate whether a preoperative positron emission tomography (PET) after a conclusive or inconclusive nonsurgical workup will r
Autor:
Ernst-Jan M. Speel, Frans C. S. Ramaekers, Anne-Marie C. Dingemans, Egbert F. Smit, Wouter W. de Herder, Dorian R.A. Swarts, Y. M. H. Jonkers, Sandra M.H. Claessen, Ronald R. de Krijger, Frederik B. Thunnissen, Aurel Perren, Aryan Vink, Robert-Jan van Suylen, Cornelis A. Seldenrijk
Publikováno v:
Swarts, D R, Claessen, S M, Jonkers, Y M, van Suylen, R J, Dingemans, A M C, de Herder, W W, de Krijger, R R, Smit, E F, Thunnissen, F B J M, Seldenrijk, C A, Vink, A, Perren, A, Ramaekers, F C S & Speel, E J M 2011, ' Deletions of 11q22.3-q25 Are Associated with Atypical Lung Carcinoids and Poor Clinical Outcome ', The American Journal of Pathology, vol. 179, no. 3, pp. 1129-1137 . https://doi.org/10.1016/j.ajpath.2011.05.028
American Journal of Pathology, 179(3), 1129-1137. Elsevier Inc.
The American Journal of Pathology, 179(3), 1129-1137. Elsevier Inc.
American Journal of Pathology, 179(3), 1129-1137. Elsevier Science
American Journal of Pathology, 179(3), 1129-1137. Elsevier Inc.
The American Journal of Pathology, 179(3), 1129-1137. Elsevier Inc.
American Journal of Pathology, 179(3), 1129-1137. Elsevier Science
Carcinoids are slow-growing neuroendocrine tumors that, in the lung, can be subclassified as typical (TC) or atypical (AC). To identify genetic alterations that improve the prediction of prognosis, we investigated 34 carcinoid tumors of the lung (18
Autor:
Katrien Grünberg, L. Arnold Noorduijn, Anne Wiersma-Van Tilburg, Bart Vrugt, Frederik B. Thunnissen, Robert J. Van Suylen, Wim Timens, Michael A Vden Bakker, Matthijs F. M. van Oosterhout, Sten P. Willemsen
Publikováno v:
Histopathology, 56(3), 356-363. Wiley
Histopathology, 56(3), 356-363. Wiley-Blackwell
den Bakker, M A, Willemsen, S, Grünberg, K, Noorduijn, L A, van Oosterhout, M F M, van Suylen, R J, Timens, W, Vrugt, B, van Tilburg, A & Thunnissen, F B J M 2010, ' Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability ', Histopathology, vol. 56, no. 3, pp. 356-363 . https://doi.org/10.1111/j.1365-2559.2010.03486.x
Histopathology, 56(3), 356-363. Wiley-Blackwell Publishing Ltd
Histopathology, 56(3), 356-363. Wiley-Blackwell
den Bakker, M A, Willemsen, S, Grünberg, K, Noorduijn, L A, van Oosterhout, M F M, van Suylen, R J, Timens, W, Vrugt, B, van Tilburg, A & Thunnissen, F B J M 2010, ' Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability ', Histopathology, vol. 56, no. 3, pp. 356-363 . https://doi.org/10.1111/j.1365-2559.2010.03486.x
Histopathology, 56(3), 356-363. Wiley-Blackwell Publishing Ltd
Aims: To test the hypothesis that the published morphological criteria permit reliable segregation of small cell carcinoma of the lung (SCLC) and large cell neuroendocrine carcinoma (LCNEC) cases by determining the interobserver variation.Methods and
Autor:
Narayan Shivapurkar, Adi F. Gazdar, John K. Field, Victor Stastny, John D. Minna, Frederik B. Thunnissen, Yang Xie, Ignacio I. Wistuba, Luc Girard, Triantafillos Liloglou, Bogdan Czerniak, Naoki Okumura, Clemens F.M. Prinsen, George Xinarianos, Jack A. Roth, Eugene P. Frenkel
Publikováno v:
Shivapurkar, N, Stastny, V, Okumura, N, Girard, L, Xie, Y, Prinsen, C, Thunnissen, F B J M, Wistuba, I I, Czerniak, B, Frenkel, E, Roth, J A, Liloglou, T, Xinarianos, G, Field, J K, Minna, J D & Gazdar, A F 2008, ' Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene ', Cancer Research, vol. 68, no. 18, pp. 7448-7456 . https://doi.org/10.1158/0008-5472.CAN-08-0565
Cancer Research, 68(18), 7448-7456. American Association for Cancer Research Inc.
Cancer Research, 68(18), 7448-7456. American Association for Cancer Research Inc.
Cytoglobin (CYGB) is a recently discovered vertebrate globin distantly related to myoglobin with unknown function. CYGB is assigned to chromosomal region 17q25, which is frequently lost in multiple malignancies. Previous studies failed to detect evid
Autor:
Eugene P. Frenkel, Bogdan Czerniak, Victor Stastny, John D. Minna, Narayan Shivapurkar, Clemens F.M. Prinsen, Adi F. Gazdar, Frederik B. Thunnissen, Yang Xie
Publikováno v:
Shivapurkar, N, Stastny, V, Xie, Y, Prinsen, C, Frenkel, E, Czerniak, B, Thunnissen, F B J M, Minna, J D & Gazdar, A F 2008, ' Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay ', Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 4, pp. 995-1000 . https://doi.org/10.1158/1055-9965.EPI-07-2808
Cancer Epidemiology Biomarkers and Prevention, 17(4), 995-1000. American Association for Cancer Research Inc.
Cancer Epidemiology Biomarkers and Prevention, 17(4), 995-1000. American Association for Cancer Research Inc.
Detection of cancer cells at early stages could potentially increase survival rates in cancer patients. Aberrant promoter hypermethylation is a major mechanism for silencing tumor suppressor genes in many kinds of human cancers. A recent report from
Autor:
Narayan Shivapurkar, Yingye Zheng, Ignacio I. Wistuba, Clemens F.M. Prinsen, Ziding Feng, Victor Stastny, Bernard Hol, Adi F. Gazdar, Frederik B. Thunnissen, Makoto Suzuki, Lin Li
Publikováno v:
Cancer Letters. 247:56-71
Detection of lung cancer at early stages could potentially increase survival rates. One promising approach is the application of suitable lung cancer-specific biomarkers to specimens obtained by non-invasive methods. Thus far, clinically useful bioma